Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.75 USD
−453.90 M USD
705.14 M USD
158.08 M
About Ionis Pharmaceuticals, Inc.
Sector
Industry
CEO
Brett P. Monia
Website
Headquarters
Carlsbad
Founded
1989
ISIN
US4622221004
FIGI
BBG000JH6683
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
IONS5835891
Ionis Pharmaceuticals, Inc. 1.75% 15-JUN-2028Yield to maturity
—
Maturity date
Jun 15, 2028
IONS5397611
Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026Yield to maturity
—
Maturity date
Apr 1, 2026
See all IONS bonds
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Ionis Pharmaceuticals, Inc. stocks are traded under the ticker IONS.
We've gathered analysts' opinions on Ionis Pharmaceuticals, Inc. future price: according to them, IONS price has a max estimate of 96.00 USD and a min estimate of 43.00 USD. Watch IONS chart and read a more detailed Ionis Pharmaceuticals, Inc. stock forecast: see what analysts think of Ionis Pharmaceuticals, Inc. and suggest that you do with its stocks.
IONS reached its all-time high on Jul 26, 2024 with the price of 56.17 USD, and its all-time low was 25.28 USD and was reached on Apr 9, 2025. View more price dynamics on IONS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Ionis Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Ionis Pharmaceuticals, Inc. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
IONS earnings for the last quarter are 0.70 USD per share, whereas the estimation was −0.09 USD resulting in a 868.38% surprise. The estimated earnings for the next quarter are −1.23 USD per share. See more details about Ionis Pharmaceuticals, Inc. earnings.
Ionis Pharmaceuticals, Inc. revenue for the last quarter amounts to 452.00 M USD, despite the estimated figure of 298.30 M USD. In the next quarter, revenue is expected to reach 130.10 M USD.
IONS net income for the last quarter is 123.55 M USD, while the quarter before that showed −146.94 M USD of net income which accounts for 184.08% change. Track more Ionis Pharmaceuticals, Inc. financial stats to get the full picture.
No, IONS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 4, 2025, the company has 1.07 K employees. See our rating of the largest employees — is Ionis Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ionis Pharmaceuticals, Inc. EBITDA is −244.09 M USD, and current EBITDA margin is −64.26%. See more stats in Ionis Pharmaceuticals, Inc. financial statements.
Like other stocks, IONS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ionis Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.